
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses
Drug delivery,pain,oncology,single-walled carbon nanotubes,opioids,abuse deterrent technology,overdose protection,and prodrug
Ensysce biosciences operates in the Biotechnology research industry.
Ensysce biosciences's revenue is 11m - 100m
Ensysce biosciences has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.